Min, T., & Bain, S. C. (2020). The Role of Tirzepatide, Dual GIP and GLP-1 Receptor Agonist, in the Management of Type 2 Diabetes: The SURPASS Clinical Trials. Diabetes Ther.
Chicago Style CitationMin, Thinzar, i Stephen C. Bain. "The Role of Tirzepatide, Dual GIP and GLP-1 Receptor Agonist, in the Management of Type 2 Diabetes: The SURPASS Clinical Trials." Diabetes Ther 2020.
Cita MLAMin, Thinzar, i Stephen C. Bain. "The Role of Tirzepatide, Dual GIP and GLP-1 Receptor Agonist, in the Management of Type 2 Diabetes: The SURPASS Clinical Trials." Diabetes Ther 2020.
Atenció: Aquestes cites poden no estar 100% correctes.